[Mechanical thrombectomy:recent advancement of the clinical trials].
Mechanical thrombectomy has become the first choice for the treatment of acute ischemic stroke caused by large vessel occlusion since 2015. Over the past decade, on the basis of early clinical practice and research,mechanical thrombectomy has advanced rapidly, not only in expanding the therapeutic time window for mechanical thrombectomy but also in the necessity of bridging therapy, the benefits for patients with large infarct cores, basilar artery thrombectomy, thrombectomy for medium vessel occlusion, and the choice of thrombectomy methods. In the future, mechanical thrombectomy will bring benefits to more patients with ischemic stroke,through persistently explore, expanding the indications of mechanical thrombectomy, continuously optimizing patient selection, and improving the recanalization rate.
Authors
- Jun Lü (ORCID: https://orcid.org/0000-0001-5281-1129)
- D M Wang
- Xiaofeng Yang (ORCID: https://orcid.org/0000-0002-1707-1388)
- J J Wang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-02-12
- DOI
- https://doi.org/10.3760/cma.j.cn112139-20241018-00466
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article